Oncogenic Viral Infections Among Iranian Hemodialysis Patients: A Systematic Review.
Hemodialysis
Iran
infections
oncogenic viral
systematic review
Journal
International journal of preventive medicine
ISSN: 2008-7802
Titre abrégé: Int J Prev Med
Pays: Iran
ID NLM: 101535380
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
10
2017
accepted:
25
11
2017
entrez:
14
1
2020
pubmed:
14
1
2020
medline:
14
1
2020
Statut:
epublish
Résumé
Chronic hemodialysis is a lifesaving procedure for end-stage renal failure patients who may lead to the transmission of oncogenic viral infections discussed as a major cause of liver disease and a potential cause of substantial morbidity and mortality. In this regard, the hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common infections that studied recently. This study aimed to review systematically all available documents on the prevalence of hepatitis D virus (HED), hepatitis E virus (HEV), hepatitis G virus (HGV), human T-lymphotropic virus (HTLV), human immunodeficiency virus (HIV), and Kaposi's sarcoma-associated herpes virus (KSHV) in Iranian hemodialysis patients. We conducted a comprehensive systematic review of literature on the prevalence and factors associated with HED, HEV, HGV, HTLV, HIV, and KSHV in Iranian hemodialysis patients. Using Medical Subject Headings (MeSH) terms, Emtree, and related equal Persian key words, irrespective of age, date, and language, the main domestic databanks of Barekat, Scientific Information Database (SID), Iran-doc, and also international databases of PubMed and NLM Gateway (for MEDLINE), Institute of Scientific Information (ISI), and SCOPUS searched. Interest outcome of infection prevalence was confirmed based on reported positive tests of blood samples. Since the studied factors are very numerous and there is even a high heterogeneity in each factor, so the meta-analysis was not performed. Based on our search strategy through comprehensive searching, 509 studies were found. From them, 314 articles were from international data bases and others from Iranian data banks. After excluding duplicates and overlapping studies, 41 studies were included in the analysis; 11 studies were relevant to HIV, 10 studies assigned to HEV, and 7 studies belonged to HGV field. The HDV, HTLV1,2, and KSHV were the other research subject areas. The prevalence of HIV, HGV, and HTLV1,2 ranged from 0% to 1.5%, 0% to 24.19%, and 0.6% to 70.4%, respectively, in different provinces. This is the comprehensive systematic review on oncogenic viral infections prevalence in the Iranian hemodialysis patients. Present findings emphasize on requirement to evidence-based practical intervention for better prevention and control of problem. The findings could be used as a scientific evidence for developing related policies and highlighting the future plan of complementary researches.
Identifiants
pubmed: 31929863
doi: 10.4103/ijpvm.IJPVM_458_17
pii: IJPVM-10-216
pmc: PMC6941381
doi:
Types de publication
Journal Article
Langues
eng
Pagination
216Informations de copyright
Copyright: © 2019 International Journal of Preventive Medicine.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
J Transl Int Med. 2015 Jun-Sep;3(3):93-105
pubmed: 27847896
Cold Spring Harb Perspect Med. 2014 Nov 03;4(11):a021550
pubmed: 25368018
Int Urol Nephrol. 2007;39(4):1257-63
pubmed: 17786579
Hepat Mon. 2010 Spring;10(2):110-5
pubmed: 22312383
Hepat Mon. 2016 Aug 13;16(10):e40375
pubmed: 27882069
AIDS. 2014 Feb 20;28(4):453-65
pubmed: 24401642
Jundishapur J Microbiol. 2015 Mar 21;8(3):e14920
pubmed: 25834713
Jundishapur J Microbiol. 2014 Nov;7(11):e13122
pubmed: 25774276
Asian Pac J Cancer Prev. ;18(10):2833-2838
pubmed: 29072430
Hepat Mon. 2015 May 23;15(5):e26260
pubmed: 26045706
Hippokratia. 2011 Apr;15(2):120-6
pubmed: 22110292
Ann Hepatol. 2013 Mar-Apr;12(2):213-9
pubmed: 23396732
Hepat Mon. 2012 May;12(5):339-43
pubmed: 22783346
Asian J Transfus Sci. 2013 Jan;7(1):21-5
pubmed: 23559759
J Res Med Sci. 2017 Nov 28;22:123
pubmed: 29259634
Infect Agent Cancer. 2011 Apr 28;6:5
pubmed: 21527020
BMC Nephrol. 2017 Feb 15;18(1):64
pubmed: 28202003
Indian J Med Microbiol. 2005 Jan;23(1):41-3
pubmed: 15928421
Recent Results Cancer Res. 2014;193:11-32
pubmed: 24008291
World J Gastroenterol. 2016 Jun 14;22(22):5143-53
pubmed: 27298557
PLoS Pathog. 2015 Nov 06;11(11):e1005255
pubmed: 26545119
Hepat Mon. 2013 May 11;13(5):e7481
pubmed: 23914228
Cancer Causes Control. 1991 Jan;2(1):37-52
pubmed: 1873433
Jundishapur J Microbiol. 2015 May 21;8(5):e20834
pubmed: 26060569
N Engl J Med. 1988 Jan 28;318(4):219-22
pubmed: 2892132
Hepat Mon. 2015 Jan 01;15(1):e18322
pubmed: 25741370
East Mediterr Health J. 2013 Jul;19(7):608-12
pubmed: 24975304
Semin Liver Dis. 2012 Aug;32(3):228-36
pubmed: 22932971
Folia Neuropathol. 2009;47(2):182-94
pubmed: 19618340
Iran J Kidney Dis. 2018 Jan;12(1):1-9
pubmed: 29421769
Hepat Mon. 2016 Jan 23;16(1):e32971
pubmed: 27110260
Saudi J Kidney Dis Transpl. 2008 Sep;19(5):838-41
pubmed: 18711311
Hemodial Int. 2010 Jul;14(3):253-62
pubmed: 20491973
BMC Infect Dis. 2005 May 17;5:36
pubmed: 15904504
Iran J Med Sci. 2015 Sep;40(5):448-53
pubmed: 26379352
Hepat Mon. 2015 Sep 08;15(9):e23633
pubmed: 26500681
Nephrourol Mon. 2016 May 02;8(3):e37878
pubmed: 27570757
Int J Cancer. 2013 Mar 1;132(5):1133-45
pubmed: 22752881
Jundishapur J Microbiol. 2014 May;7(5):e6993
pubmed: 25147715